Friday, March 5, 2021

Dogs Could Detect Prostate Cancer from Urine Samples, Finds Study

A new study has shown that dogs could help detect an aggressive form of prostate cancer in urine samples, suggesting that this could pave way for new diagnostic tools. The study, published in the journal PLOS One, also found that the dogs detected prostate cancer with a high degree of accuracy.

New Treatment Found Effective in Preventing Spread of Melanoma, Study

An Australian study has found that a new drug therapy given before surgery is effective in preventing the spread of melanoma, a type of skin cancer. The new drug treatment is called neoadjuvant therapy. The study found that pre-operative targeted immunotherapy was effective in patients with stage 3 melanoma.

Dustin Diamond Begins Chemo for Stage 4 Lung Cancer

Dustin Diamond, the Saved by the Bell alum, has started chemotherapy for his stage 4 small cell cancer that affected his lungs. His representative said he underwent the first round of chemo, with the second round of therapy scheduled. The rep also said that Diamond is in a lot of pain.

Human Trials for Breast Cancer Vaccine Expected To Begin In 2021

The FDA has granted permission for human trials of Cleveland Clinic’s promising new breast cancer vaccine. Animal studies of the vaccine have shown promising results, with 100% of mice that did not receive the vaccine developed breast cancer and died. Human trials are expected to begin in 2021.

Multiple Sclerosis May Not Increase Risk Of Breast And Colorectal Cancers

A new study has found that people with multiple sclerosis, a devastating neurological condition, may not be at risk of developing breast and colorectal cancers. However, they could be at risk of developing bladder cancer. The Canadian study was published online in the journal Neurology.

FDA Approves Test to Identify Patients with Triple-Negative Breast Cancer for Keytruda Treatment

The U.S. Food and Drug Administration (FDA) approved the use of PD-L1 IHC 22C3 pharmDx, a lab test developed by Agilent Technologies, to identify patients with triple-negative breast cancer who may be suitable for treatment with pembrolizumab (Keytruda).

Al Roker “Back Home” After Undergoing Prostate Cancer Surgery

Al Roker has recently given an update about his health, revealing that he is now back home after undergoing prostate cancer surgery. He was diagnosed with prostate cancer on September 29 after getting an MRI and a biopsy. Roker posted a pic with his wife on Instagram to share he is doing well.